CRISPR Therapeutics AG (CRSP) Property, Plant & Equipment (Net) (2015 - 2026)
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Property, Plant & Equipment (Net) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.44 Bn | 112.79 Mn | 153.78 Mn |
| 2 | CRISPR Therapeutics AG | 5.21 Bn | 5.21 Bn | - | 108.07 Mn |
| 3 | Iovance Biotherapeutics | 3.78 Bn | 3.48 Bn | 55.72 Mn | 131.46 Mn |
| 4 | Legend Biotech | 3.69 Bn | 2.72 Bn | 251.50 Mn | 125.90 Mn |
| 5 | uniQure | 3.06 Bn | 3.06 Bn | 5.49 Mn | 11.38 Mn |
| 6 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - | 97.61 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 12.80 Mn |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.55 Bn | 251.87 Mn | 325.99 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 105.60 Mn |
| 10 | Taysha Gene Therapies | 1.99 Bn | 1.99 Bn | - | 2.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.07 Mn |
| Mar 31, 2026 | 112.18 Mn |
| Dec 31, 2025 | 115.85 Mn |
| Sep 30, 2025 | 120.83 Mn |
| Jun 30, 2025 | 124.93 Mn |
| Mar 31, 2025 | 129.43 Mn |
| Dec 31, 2024 | 134.09 Mn |
| Sep 30, 2024 | 138.54 Mn |
| Jun 30, 2024 | 143.03 Mn |
| Mar 31, 2024 | 147.25 Mn |
| Dec 31, 2023 | 151.95 Mn |
| Sep 30, 2023 | 156.12 Mn |
| Jun 30, 2023 | 159.17 Mn |
| Mar 31, 2023 | 162.20 Mn |
| Dec 31, 2022 | 163.63 Mn |
| Sep 30, 2022 | 166.11 Mn |
| Jun 30, 2022 | 165.19 Mn |
| Mar 31, 2022 | 157.45 Mn |
| Dec 31, 2021 | 137.58 Mn |
| Sep 30, 2021 | 105.88 Mn |